Literature DB >> 26313473

Injuries from Methamphetamine-Related Chemical Incidents - Five States, 2001-2012.

Natalia Melnikova, Maureen F Orr, Jennifer Wu, Bryan Christensen.   

Abstract

Methamphetamine (meth), a highly addictive drug, can be illegally manufactured using easily acquired chemicals; meth production can cause fires, explosions, injuries, and environmental contamination. To analyze injury incidence and trends, data on 1,325 meth-related chemical incidents reported to the Agency for Toxic Substances and Disease Registry's (ATSDR) Hazardous Substances Emergency Events Surveillance (HSEES) system and National Toxic Substance Incidents Program (NTSIP) by the five participating states (Louisiana, Oregon, Utah, New York, and Wisconsin) with complete information during 2001-2012 were examined. The findings suggested that meth-related chemical incidents increased with the drug's popularity (2001-2004), declined with legislation limiting access to precursor chemicals (2005-2007), and increased again as drug makers circumvented precursor restrictions (2008-2012). Seven percent of meth-related chemical incidents resulted in injuries to 162 persons, mostly members of the general public (97 persons, including 26 children) and law enforcement officials (42). Recent trends suggest a need for efforts to protect the general public, particularly children and law enforcement officials. Because individual state legislative actions can result in increased illegal meth production in neighboring states, a regional approach to prevention is recommended.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26313473     DOI: 10.15585/mmwr.mm6433a4

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  1 in total

1.  Acute Chemical Incidents With Injured First Responders, 2002-2012.

Authors:  Natalia Melnikova; Jennifer Wu; Alice Yang; Maureen Orr
Journal:  Disaster Med Public Health Prep       Date:  2017-08-01       Impact factor: 1.385

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.